Clinical Trial Update: Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma [Phase 2]

View source ↗

Summary

A Phase II trial for loco-regional esophageal cancer sponsored by the University of Michigan Rogel Cancer Center was terminated, but its results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Loco-regional Esophageal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-01-12